The Combined Effect of the Mediterranean Diet and Intermittent Fasting on Hypertension
- Hypertension
At a glance
- Phase
- Phase not stated
- Study type
- Interventional
- Sponsor
- Nadide Gizem Tarakci Filiz
- Enrolment target
- 48
- Started
- 13 December 2025
- Main results due
- 15 December 2026
- Study sites
- 1
- Registry updated
- 25 September 2026
Can you take part?
- Ages 40 years to 65 years.
- Open to any sex.
- You need the condition being studied — healthy volunteers are not accepted.
These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.
Read the full eligibility criteria
Inclusion Criteria: * Newly diagnosed hypertension patients * Individuals with blood pressure \>140/90 mmHg * Individuals with a body mass index (BMI) in the range of 18.5-25 kg/m² * Individuals aged 40-65 years Exclusion Criteria: Participants will be excluded if they have any of the following: * Type 2 Diabetes Mellitus * Type 1 Diabetes Mellitus * Cardiovascular disease * Liver disease * Kidney disease * Gastrointestinal disease * Respiratory disease * Psychiatric disorders * Women who are pregnant or breastfeeding * Severe food allergies * Current smokers or individuals consuming alcohol regularly * History of major surgery within the last 6 months
What this study is about
In the sponsor’s own words, from the registry.
Hypertension (HT) is an important risk factor for cardiovascular diseases (CVD) and death. Approximately 16.9 million people in Turkey have HT. Nutritional habits play an important role in the development of HT. DASH (Dietary Approaches to Stop Hypertension) and the Mediterranean diet (MD) have been found to be effective in lowering blood pressure and reducing cardiometabolic risks. The DASH diet stands out with its low sodium, saturated fat, simple sugar and cholesterol content, while it is rich in fiber, potassium, magnesium and anti-inflammatory components. The MD is based on healthy foods such as olive oil, vegetables, fruits, fish and nuts, and contains antioxidants and healthy fatty acids. This study will investigate whether the sodium-restricted MD can offer a model comparable to DASH. In addition, the effects of the intermittent fasting diet (IFD) model alone and in combination with the MD on blood pressure will be examined. It has been observed that IFD reduces blood pressure by reducing energy intake and acting on the autonomic nervous system. The aim of this project is to evaluate the effects of MD, IFD and both of them on hypertension and to present a new and original approach in this field.
Study sites(1)
Medipol Mega University Hospital
Istanbul, Turkey (Türkiye)
Recruiting
Showing 1 of 1 sites. 1 of the 1 site on this study is recruiting right now — a site can stop enrolling while the study as a whole is still open.
Source: ClinicalTrials.gov record NCT07189637. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.
Not the right study?
Answer three questions and see the studies recruiting near you, in plain language.
Find a study for me